Immune Regulatory Effects of Sinomenine on Primary Membranous Nephropathy: Based on Case Report and Network Pharmacology

Abstract

PMN an organ-specific autoimmune disease, is the leading cause of nephrotic syndrome (NS) in adults worldwide. However, there is no specific treatment for PMN other than optimal supportive care in low and moderate risk PMN. Immunosuppressive therapy is restricted to patients considered at risk for progressive kidney injury.